Embera NeuroTherapeutics' Series A - III Round

Embera NeuroTherapeutics raised a round of funding on September 29, 2015.

Embera NeuroTherapeutics is a development-stage pharmaceutical company focused on treating a broad range of addictions where the major clinical challenge is a limited range of effective therapies. Emb…

Articles about Embera NeuroTherapeutics' Series A - III Round: